{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:20:56Z","timestamp":1784996456615,"version":"3.55.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Secondary hyperparathyroidism (SHPT) affects nearly all patients on maintenance dialysis therapy. SHPT treatment options have considerably evolved over the past 2 decades but vary in degree of improvement in SHPT. Therefore, we hypothesize that the risks of adverse outcomes after kidney transplantation (KT) may differ by SHPT treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Using the Scientific Registry of Transplant Recipients and Medicare claims data, we identified 5094 adults (age \u226518 y) treated with cinacalcet or parathyroidectomy for SHPT before receiving KT between 2007 and 2016. We quantified the association between SHPT treatment and delayed graft function and acute rejection using adjusted logistic models and tertiary hyperparathyroidism (THPT), graft failure, and death using adjusted Cox proportional hazards; we tested whether these associations differed by patient characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Of 5094 KT recipients who were treated for SHPT while on dialysis, 228 (4.5%) underwent parathyroidectomy, and 4866 (95.5%) received cinacalcet. There was no association between treatment of SHPT and posttransplant delayed graft function, graft failure, or death. However, compared with patients treated with cinacalcet, those treated with parathyroidectomy had a lower risk of developing THPT (adjusted hazard ratio, 0.56; 95% confidence interval, 0.35-0.89) post-KT. Furthermore, this risk differed by dialysis vintage (<jats:italic toggle=\"yes\">P<\/jats:italic>\n                                 <jats:sub>interaction<\/jats:sub>\u2009=\u20090.039). Among patients on maintenance dialysis therapy for \u22653 y before KT (n\u2009=\u20093477, 68.3%), the risk of developing THPT was lower when treated with parathyroidectomy (adjusted hazard ratio, 0.43; 95% confidence interval, 0.24-0.79).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Parathyroidectomy should be considered as treatment for SHPT, especially in KT candidates on maintenance dialysis for \u22653 y. Additionally, patients treated with cinacalcet for SHPT should undergo close surveillance for development of tertiary hyperparathyroidism post-KT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003653","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T16:54:07Z","timestamp":1612803247000},"page":"e366-e374","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes"],"prefix":"10.1097","volume":"105","author":[{"given":"Aarti","family":"Mathur","sequence":"first","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiYoon B.","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Prescott","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Zeiger","sequence":"additional","affiliation":[{"name":"Surgical Oncology Program, National Cancer Institute, National Institute of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"McAdams-DeMarco","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2215\/CJN.10390917","article-title":"Parathyroidectomy in the management of secondary hyperparathyroidism.","volume":"13","author":"Lau","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2215\/CJN.10370915","article-title":"Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States.","volume":"11","author":"Kim","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial.","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"2020-1-1","DOI":"10.7573\/dic.2020-1-1","article-title":"Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs.","volume":"9","author":"Roggeri","year":"2020","journal-title":"Drugs Context"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21037\/gs.2020.03.08","article-title":"Therapeutic efficacy of two surgical methods on the secondary hyperparathyroidism.","volume":"9","author":"Gu","year":"2020","journal-title":"Gland Surg"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.transproceed.2004.07.011","article-title":"Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.","volume":"36","author":"Rashed","year":"2004","journal-title":"Transplant Proc"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral And Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters.","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11255-018-1838-5","article-title":"Calcimimetics versus parathyroidectomy: what is preferable?","volume":"50","author":"Rroji","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.surg.2018.04.090","article-title":"Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival.","volume":"165","author":"Finnerty","year":"2019","journal-title":"Surgery"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.tp.0000228923.75739.88","article-title":"High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.","volume":"82","author":"Roodnat","year":"2006","journal-title":"Transplantation"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.surg.2016.10.003","article-title":"Parathyroidectomy prior to kidney transplant decreases graft failure.","volume":"161","author":"Callender","year":"2017","journal-title":"Surgery"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/SLA.0000000000001431","article-title":"How well does renal transplantation cure hyperparathyroidism?","volume":"262","author":"Lou","year":"2015","journal-title":"Ann Surg"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-0012.2010.01287.x","article-title":"Therapeutic management of post-kidney transplant hyperparathyroidism.","volume":"25","author":"Copley","year":"2011","journal-title":"Clin Transplant"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","article-title":"Secondary and tertiary hyperparathyroidism, state of the art surgical management.","volume":"89","author":"Pitt","year":"2009","journal-title":"Surg Clin North Am"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.12777","article-title":"Big data in organ transplantation: registries and administrative claims.","volume":"14","author":"Massie","year":"2014","journal-title":"Am J Transplant"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/TP.0b013e318259407f","article-title":"The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation.","volume":"94","author":"Lentine","year":"2012","journal-title":"Transplantation"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12877-018-0940-y","article-title":"Pre-kidney transplant lower extremity impairment and transplant length of stay: a time-to-discharge analysis of a prospective cohort study.","volume":"18","author":"Nastasi","year":"2018","journal-title":"BMC Geriatr"},{"key":"R24-20250607","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights.","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/nep.12536","article-title":"Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.","volume":"21","author":"Sharma","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imj.14036","article-title":"Outcomes of cinacalcet withdrawal in Australian dialysis patients.","volume":"49","author":"Ruderman","year":"2019","journal-title":"Intern Med J"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-0012.2011.01524.x","article-title":"Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.","volume":"26","author":"Evenepoel","year":"2012","journal-title":"Clin Transplant"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2215\/CJN.15081218","article-title":"Medication prescription patterns for secondary hyperparathyroidism: more questions than answers.","volume":"14","author":"Seethapathy","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.09550818","article-title":"Variability in cinacalcet prescription across US hemodialysis facilities.","volume":"14","author":"Fuller","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00268-019-05207-4","article-title":"Effects of social disparities on management and surgical outcomes for patients with secondary hyperparathyroidism.","volume":"44","author":"Greene","year":"2020","journal-title":"World J Surg"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2010.10.041","article-title":"Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007.","volume":"57","author":"Li","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000350213","article-title":"Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients.","volume":"37","author":"Kilpatrick","year":"2013","journal-title":"Am J Nephrol"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/bjs.10554","article-title":"Systematic review of surgical and medical treatment for tertiary hyperparathyroidism.","volume":"104","author":"Dulfer","year":"2017","journal-title":"Br J Surg"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000368514","article-title":"Long-term outcomes of parathyroidectomy in kidney transplant recipients with persistent hyperparathyroidism.","volume":"40","author":"Tseng","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.","volume":"99","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplantation"},{"key":"R37-20250607","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.surg.2017.12.010","article-title":"Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy.","volume":"163","author":"Araujo","year":"2018","journal-title":"Surgery"},{"key":"R38-20250607","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/ctr.12341","article-title":"Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.","volume":"28","author":"Bleskestad","year":"2014","journal-title":"Clin Transplant"},{"key":"R39-20250607","doi-asserted-by":"crossref","first-page":"e14085","DOI":"10.1111\/ctr.14085","article-title":"Early persistent hyperparathyroidism post-renal transplantation as a predictor of worse graft function and mortality after transplantation.","volume":"34","author":"Isakov","year":"2020","journal-title":"Clin Transplant"},{"key":"R40-20250607","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ctr.12099","article-title":"Impact of post-kidney transplant parathyroidectomy on allograft function.","volume":"27","author":"Parikh","year":"2013","journal-title":"Clin Transplant"},{"key":"R41-20250607","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/ndt\/gfm044","article-title":"Parathyroidectomy after successful kidney transplantation: a single centre study.","volume":"22","author":"Evenepoel","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R42-20250607","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","article-title":"Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.","volume":"49","author":"Narayan","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R43-20250607","first-page":"54","article-title":"Pre-transplant calcium-phosphate-parathormone homeostasis as a risk factor for early graft dysfunction.","volume":"19","author":"Ahmadi","year":"2008","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R44-20250607","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.TP.0000116417.03114.87","article-title":"Calcium levels as a risk factor for delayed graft function.","volume":"77","author":"Boom","year":"2004","journal-title":"Transplantation"},{"key":"R45-20250607","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.surg.2017.10.016","article-title":"Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy.","volume":"163","author":"Littbarski","year":"2018","journal-title":"Surgery"},{"key":"R46-20250607","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00268-019-05124-6","article-title":"Comparison of pre- and post-transplant parathyroidectomy in renal transplant recipients and the impact of parathyroidectomy timing on calcium metabolism and renal allograft function: a retrospective single-center analysis.","volume":"44","author":"Okada","year":"2020","journal-title":"World J Surg"},{"key":"R47-20250607","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.transproceed.2020.03.024","article-title":"Influence of parathyroidectomy on kidney graft function in secondary and tertiary hyperparathyroidism.","volume":"52","author":"Bures","year":"2020","journal-title":"Transplant Proc"},{"key":"R48-20250607","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/TP.0b013e3182530699","article-title":"Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies.","volume":"94","author":"Yang","year":"2012","journal-title":"Transplantation"},{"key":"R49-20250607","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/ajt.16106","article-title":"Characterizing the landscape and impact of infections following kidney transplantation.","volume":"21","author":"Jackson","year":"2021","journal-title":"Am J Transplant"},{"key":"R50-20250607","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ajt.12563","article-title":"Sequelae of early hospital readmission after kidney transplantation.","volume":"14","author":"McAdams-Demarco","year":"2014","journal-title":"Am J Transplant"},{"key":"R51-20250607","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archsurg.139.9.974","article-title":"Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.","volume":"139","author":"Kebebew","year":"2004","journal-title":"Arch Surg"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:12:09Z","timestamp":1749312729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003653","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]}}}